Ir para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Palavra solta
Título
Autor
Assunto
Área/Cota
ISBN/ISSN
Tag
Pesquisar
Avançada
Adalimumab sustains improvemen...
Citar
Enviar por SMS
Enviar por email
Imprimir
Exportar registo
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Permanent link
Adalimumab sustains improvement in spinal mobility in as patients through 104 weeks - Results from atlas
Detalhes bibliográficos
Main Authors:
Wordsworth, P
,
Dijkmans, B
,
van der Heijde, D
,
Davis, J
,
Schiff, M
,
Kivitz, A
,
Sieper, J
,
Mease, P
,
Kupper, H
,
Wong, R
,
Grp, A
Formato:
Conference item
Publicado em:
2008
Exemplares
Descrição
Registos relacionados
Registo fonte
Registos relacionados
CLINICAL RESPONSE AND PARTIAL REMISSION SUSTAINED THROUGH 3 YEARS OF ADALIMUMAB TREATMENT IN THE ATLAS TRIAL
Por: Wordsworth, P, et al.
Publicado em: (2009)
Treatment with adalimumab reduces signs and symptoms and induces partial remission in patients with ankylosing spondylitis (AS): 1-year results from ATLAS.
Por: van der Heijde, D, et al.
Publicado em: (2006)
Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS)
Por: van der Heijde, D, et al.
Publicado em: (2008)
Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial.
Por: Van der Heijde, D, et al.
Publicado em: (2005)
Adalimumab enhances health-related quality of life in patients with active ankylosing spondylitis - Results from the atlas trial
Por: van der Heijde, D, et al.
Publicado em: (2006)